ProtoKinetix, Incorporated (OTCMKTS:PKTX – Get Free Report) shares passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.01 and traded as low as $0.0056. ProtoKinetix shares last traded at $0.0056, with a volume of 272,915 shares changing hands.
ProtoKinetix Stock Up 7.7%
The firm has a fifty day moving average of $0.01 and a 200-day moving average of $0.01.
ProtoKinetix Company Profile
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing. It has a collaboration research agreement with the University of British Columbia. The company was formerly known as RJV Network, Inc and changed its name to ProtoKinetix, Incorporated in July 2003.
Read More
- Five stocks we like better than ProtoKinetix
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Receive News & Ratings for ProtoKinetix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProtoKinetix and related companies with MarketBeat.com's FREE daily email newsletter.
